Clinical Trial: Stemchymal(R) for Polyglutamine Spinocerebellar Ataxia

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06397274) titled 'Stemchymal(R) for Polyglutamine Spinocerebellar Ataxia' on April 29.

Brief Summary: The purpose of the clinical trial is to study the therapeutic efficacy and safety of Stemchymal(R) infusions for polyglutamine spinocerebellar ataxia treatment by a randomized, double-blind, placebo-controlled study design. Eligible subjects will receive Stemchymal(R) through intravenous infusion.

Study Type: Interventional

Condition: Spinocerebellar Ataxias

Intervention: * Biological: Stemchymal

Patients will receive Stemchymal(R) through intravenous infusion

* Biological: Placebo

Patients will receive Placebo through intravenous infusion

Recru...